Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 166

1.

The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia.

Salmon AM, van Beek I, Amin J, Kaldor J, Maher L.

Addiction. 2010 Apr;105(4):676-83. doi: 10.1111/j.1360-0443.2009.02837.x. Epub 2010 Feb 9.

PMID:
20148794
[PubMed - indexed for MEDLINE]
2.

Shooting gallery operation in the context of establishing a medically supervised injecting center: Sydney, Australia.

Kimber J, Dolan K.

J Urban Health. 2007 Mar;84(2):255-66.

PMID:
17273925
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Ambulance calls to suspected overdoses: New South Wales patterns July 1997 to June 1999.

Degenhardt L, Hall W, Adelstein BA.

Aust N Z J Public Health. 2001 Oct;25(5):447-50.

PMID:
11688626
[PubMed - indexed for MEDLINE]
4.

The Sydney Medically Supervised Injecting Centre: a controversial public health measure.

Kelly C, Conigrave KM.

Aust N Z J Public Health. 2002 Dec;26(6):552-4.

PMID:
12530800
[PubMed - indexed for MEDLINE]
5.

Five years on: what are the community perceptions of drug-related public amenity following the establishment of the Sydney Medically Supervised Injecting Centre?

Salmon AM, Thein HH, Kimber J, Kaldor JM, Maher L.

Int J Drug Policy. 2007 Jan;18(1):46-53. Epub 2007 Jan 8.

PMID:
17689343
[PubMed - indexed for MEDLINE]
6.

Injecting-related injury and disease among clients of a supervised injecting facility.

Salmon AM, Dwyer R, Jauncey M, van Beek I, Topp L, Maher L.

Drug Alcohol Depend. 2009 Apr 1;101(1-2):132-6. doi: 10.1016/j.drugalcdep.2008.12.002. Epub 2009 Jan 23.

PMID:
19167171
[PubMed - indexed for MEDLINE]
7.

Characteristics of non-fatal opioid overdoses attended by ambulance services in Australia.

Dietze P, Jolley D, Cvetkovski S, Cantwell K, Jacobs I, Indig D.

Aust N Z J Public Health. 2004 Dec;28(6):569-75.

PMID:
15707208
[PubMed - indexed for MEDLINE]
8.

A micro-environmental intervention to reduce the harms associated with drug-related overdose: evidence from the evaluation of Vancouver's safer injection facility.

Kerr T, Small W, Moore D, Wood E.

Int J Drug Policy. 2007 Jan;18(1):37-45. Epub 2007 Jan 16.

PMID:
17689342
[PubMed - indexed for MEDLINE]
9.

Effects of a sustained heroin shortage in three Australian States.

Degenhardt L, Day C, Dietze P, Pointer S, Conroy E, Collins L, Hall W.

Addiction. 2005 Jul;100(7):908-20.

PMID:
15954999
[PubMed - indexed for MEDLINE]
10.

The potential public health and community impacts of safer injecting facilities: evidence from a cohort of injection drug users.

Wood E, Kerr T, Spittal PM, Li K, Small W, Tyndall MW, Hogg RS, O'Shaughnessy MV, Schechter MT.

J Acquir Immune Defic Syndr. 2003 Jan 1;32(1):2-8.

PMID:
12514408
[PubMed - indexed for MEDLINE]
11.

Do supervised injecting facilities attract higher-risk injection drug users?

Wood E, Tyndall MW, Li K, Lloyd-Smith E, Small W, Montaner JS, Kerr T.

Am J Prev Med. 2005 Aug;29(2):126-30.

PMID:
16005809
[PubMed - indexed for MEDLINE]
12.

The impact of the Sydney Medically Supervised Injecting Centre (MSIC) on crime.

Freeman K, Jones CG, Weatherburn DJ, Rutter S, Spooner CJ, Donnelly N.

Drug Alcohol Rev. 2005 Mar;24(2):173-84.

PMID:
16076587
[PubMed - indexed for MEDLINE]
13.

Attendance, drug use patterns, and referrals made from North America's first supervised injection facility.

Tyndall MW, Kerr T, Zhang R, King E, Montaner JG, Wood E.

Drug Alcohol Depend. 2006 Jul 27;83(3):193-8. Epub 2005 Dec 13.

PMID:
16356659
[PubMed - indexed for MEDLINE]
14.

Estimating the size and dynamics of an injecting drug user population and implications for health service coverage: comparison of indirect prevalence estimation methods.

Kimber J, Hickman M, Degenhardt L, Coulson T, van Beek I.

Addiction. 2008 Oct;103(10):1604-13. doi: 10.1111/j.1360-0443.2008.02276.x. Epub 2008 Jul 14.

PMID:
18638037
[PubMed - indexed for MEDLINE]
15.

Injection drug users' perceptions regarding use of a medically supervised safer injecting facility.

Petrar S, Kerr T, Tyndall MW, Zhang R, Montaner JS, Wood E.

Addict Behav. 2007 May;32(5):1088-93. Epub 2006 Aug 22.

PMID:
16930849
[PubMed - indexed for MEDLINE]
16.

The effect of a reduction in heroin supply on fatal and non-fatal drug overdoses in New South Wales, Australia.

Degenhardt LJ, Conroy E, Gilmour S, Hall WD.

Med J Aust. 2005 Jan 3;182(1):20-3.

PMID:
15651943
[PubMed - indexed for MEDLINE]
17.

Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study.

Marshall BD, Milloy MJ, Wood E, Montaner JS, Kerr T.

Lancet. 2011 Apr 23;377(9775):1429-37. doi: 10.1016/S0140-6736(10)62353-7. Epub 2011 Apr 15.

PMID:
21497898
[PubMed - indexed for MEDLINE]
18.

Preference to have used a medically supervised injecting centre among injecting drug users in Kings Cross, Sydney.

van Beek I, Gilmour S.

Aust N Z J Public Health. 2000 Oct;24(5):540-2.

PMID:
11109694
[PubMed - indexed for MEDLINE]
19.

High HIV testing and low HIV prevalence among injecting drug users attending the Sydney Medically Supervised Injecting Centre.

Salmon AM, van Beek I, Amin J, Grulich A, Maher L.

Aust N Z J Public Health. 2009 Jun;33(3):280-3. doi: 10.1111/j.1753-6405.2009.00389.x.

PMID:
19630850
[PubMed - indexed for MEDLINE]
20.

Impact of drug market changes on substance-using pregnant women in three key Sydney drug markets.

Conroy E, Degenhardt L, Day C.

Women Health. 2006;44(4):93-105.

PMID:
17456466
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk